{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-000142","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2022-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.463910+00:00","generated_at":"2026-06-27T20:56:13.727276+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Esperion appoints Benjamin O. Looker as General Counsel effective Jan 1, 2022","bullets":["Appointed Benjamin O. Looker as General Counsel effective Jan 1, 2022, reporting to CEO Sheldon Koenig.","Looker previously served as GC of Trillium Therapeutics until its acquisition by Pfizer in Nov 2021.","Compensation includes $375k base salary, 40% target bonus, option for 100,450 shares, and 70,800 RSUs.","Looker will lead legal, compliance, and ethics operations, with focus on upcoming CLEAR Outcomes trial results."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-000142","json":"https://secwatch.observer/filing/0001628280-22-000142.json","markdown":"https://secwatch.observer/filing/0001628280-22-000142.md","text":"https://secwatch.observer/filing/0001628280-22-000142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022000142/0001628280-22-000142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022000142/espr-20220104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:56:13.727276+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8852e1b7ee","claim":"Benjamin O. Looker was appointed as General Counsel at Esperion Therapeutics, Inc..","evidence_excerpt":"On January 4, 2022, Esperion Therapeutics, Inc. (the “Company”) announced the appointment of Benjamin O. Looker as the Company’s General Counsel pursuant to the terms of an employment agreement with Mr. Looker (the “Looker Agreement”), effective as of January 1, 2022 (the “Start Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022000142/0001628280-22-000142-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"General Counsel"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}